Finance

Lists
XP0:FRA
Xenon Pharmaceuticals Inc
€52.00
0.00%
(0.00) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for XP0...
Open
€52.00
High
€52.00
Low
€52.00
Mkt. cap
5.79B
Avg. vol.
21.00
Volume
0.00
52-wk high
€62.00
52-wk low
€29.80
No. of employees
364
Open
€52.00
High
€52.00
Low
€52.00
Mkt. cap
5.79B
Avg. vol.
21.00
Volume
0.00
52-wk high
€62.00
52-wk low
€29.80
No. of employees
364
News stories
From web sources and news partners
About Xenon Pharmaceuticals Inc
CEO-
Employees364
Founded1996
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitexenon-pharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
77.05M
87.70M
88.51M
99.22M
Cost of revenue
77.05M
87.70M
88.51M
99.22M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.28M
22.07M
23.82M
23.93M
Operating expense
19.28M
22.07M
23.82M
23.93M
Total operating expenses
96.34M
109.77M
112.33M
123.16M
Operating income
-96.34M
-109.77M
-112.33M
-123.16M
Other non operating income
-
-
-
-
EBT including unusual items
-90.22M
-104.72M
-104.87M
-111.32M
EBT excluding unusual items
-90.22M
-104.72M
-104.87M
-111.32M
Income tax expense
677.00K
538.00K
-2.57M
-585.00K
Effective tax rate
-0.75%
-0.51%
2.45%
0.53%
Other operating expenses
-
-
-
-
Net income
-90.90M
-105.26M
-102.30M
-110.74M
Net profit margin
-
-
-
-
Earnings per share
-1.15
-1.31
-1.17
-1.11
Interest and investment income
6.21M
5.34M
6.91M
12.14M
Interest expense
-
-
-
-
Net interest expenses
6.21M
5.34M
6.91M
12.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
-95.70M
-109.16M
-111.74M
-122.60M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps